Yew Bio-Pharm Group (Yew Bio-Pharm Group) 3-Year Dividend Growth Rate : 0.00% (As of Sep. 2021)

View and export this data going back to 2013. Start your Free Trial

What is Yew Bio-Pharm Group 3-Year Dividend Growth Rate?

Yew Bio-Pharm Group's Dividends per Share for the three months ended in Sep. 2021 was $0.00.

The historical rank and industry rank for Yew Bio-Pharm Group's 3-Year Dividend Growth Rate or its related term are showing as below:

YEWB's 3-Year Dividend Growth Rate is not ranked ^*
in the Consumer Packaged Goods industry.
Industry Median: 7.7
* Ranked among companies with meaningful 3-Year Dividend Growth Rate only.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Yew Bio-Pharm Group's Dividend Payout Ratio for the three months ended in Sep. 2021 was 0.00. As of today, Yew Bio-Pharm Group's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Yew Bio-Pharm Group's 3-Year Dividend Growth Rate

For the Farm Products subindustry, Yew Bio-Pharm Group's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Yew Bio-Pharm Group's 3-Year Dividend Growth Rate Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Yew Bio-Pharm Group's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Yew Bio-Pharm Group's 3-Year Dividend Growth Rate falls into.

Yew Bio-Pharm Group 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Yew Bio-Pharm Group (OTCPK:YEWB) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Yew Bio-Pharm Group's Dividend Payout Ratio for the quarter that ended in Sep. 2021 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Sep. 2021 )	/	EPS without NRI (Q: Sep. 2021 )
	=	0	/	-0.022
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yew Bio-Pharm Group 3-Year Dividend Growth Rate Related Terms>

Yew Bio-Pharm Group (Yew Bio-Pharm Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Yew Bio-Pharm Group Inc (OTCPK:YEWB) » Definitions » 3-Year Dividend Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

9460 Telstar Avenue, Suite 6, El Monte, CA, USA, 91731

Website

http://www.yewbiopharm.com

Yew Bio-Pharm Group Inc is a grower and seller of yew trees and manufacturer of products made from yew trees in China. The company also sells raw material, including the branches and leaves of yew trees, used in the manufacturing of traditional Chinese medicines, which are used as a secondary treatment for certain cancers, meaning they must be administered in combination with other pharmaceutical drugs. The company operating business segments are China and the United States, of which the majority of its revenue comes from China.

Executives

Yongchun Shi	director	9460 TELSTAR AVENUE, SUITE 6 EL MONTE CA 91302
Xiefeng Liu	director	9460 TELSTAR AVENUE, SUITE 6 EL MONTE CA 91731
Guoshuang Tian	director	9460 TELSTAR AVENUE, SUITE 6 EL MONTE CA 91731
Xuehai Wu	director	9460 TELSTAR AVENUE, SUITE 6 EL MONTE CA 91731
Xingming Han	director	DOOR 3, FLOOR 7, VIC NO.23 TONGZHAN ST. XIANGFANG DISTRICT HARBIN CITY F4 XXXXXXXXX
Adam C Wasserman	officer: Chief Financial Officer	1643 ROYAL GROVE WAY, WESTON FL 33327
Guifang Qi	director, officer: Treasurer	501 N. MOORE AVE. APT. A MONTEREY PARK CA 91754
Zhiguo Wang	director, officer: President and Secretary	NO. 234, GEXIN STREET NANGANG DISTRICT HARBIN CITY F4 XXXXXXXXX

Yew Bio-Pharm Group (Yew Bio-Pharm Group) Headlines

From GuruFocus

Yew Bio-Pharm Group Announces Submission of its Application to List on the Nasdaq

By Marketwired Marketwired • 09-25-2018

Yew Bio-Pharm Group Announces New Significant Agreement

By Marketwired Marketwired • 09-12-2018

Yew Bio-Pharm Group Announces New Cosmetic Subsidiary

By Marketwired Marketwired • 03-09-2021